These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19359532)

  • 21. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
    Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal-probrain natriuretic peptide and echocardiography in patients with systolic heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Saudi Med J; 2005 Nov; 26(11):1695-8. PubMed ID: 16311650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.
    Foo JY; Wan Y; Schulz BL; Kostner K; Atherton J; Cooper-White J; Dimeski G; Punyadeera C
    Clin Chem; 2013 Oct; 59(10):1523-31. PubMed ID: 23820130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macro-pro-B-type natriuretic peptide (proBNP) and hidden macro-N-terminal proBNP: Case report.
    Nakagawa Y; Nishikimi T; Sakai H; Ohno S; Kinoshita H; Inazumi H; Moriuchi K; Kuwahara K; Horie M; Kimura T
    Clin Biochem; 2018 Feb; 52():148-152. PubMed ID: 29103929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
    Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S
    Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urine measurement indicates the plasma brain natriuretic peptide concentration during optimization of heart failure treatment.
    Hahn RG; Jaarsma T; Waldréus N; Linssen GC
    Scand J Clin Lab Invest; 2016; 76(2):112-7. PubMed ID: 26577037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NGAL and NT-proBNP levels in diabetic patients with macroproteinuria.
    Taskapan H; Taskapan MC; Orman I; Ulutas O; Yigit A; Ozyalin F; Yologlu S
    Ren Fail; 2013 Oct; 35(9):1273-7. PubMed ID: 23964619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmortem urine concentration of N-terminal pro-brain natriuretic peptide in relation to the cause of death.
    Takasu S; Matsumoto S; Kanto Y; Kodama S; Iwadate K
    Forensic Sci Int; 2020 Jan; 306():110079. PubMed ID: 31812084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
    Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
    Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study.
    Carlsen CM; Bay M; Kirk V; Gøtze JP; Køber L; Nielsen OW
    Eur J Heart Fail; 2012 Mar; 14(3):240-7. PubMed ID: 22315457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
    Bal L; Thierry S; Brocas E; Van de Louw A; Pottecher J; Hours S; Moreau MH; Perrin Gachadoat D; Tenaillon A
    Acta Anaesthesiol Scand; 2006 Mar; 50(3):340-7. PubMed ID: 16480468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2006; 58(2):138-43. PubMed ID: 18989058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiating between feline pleural effusions of cardiac and non-cardiac origin using pleural fluid NT-proBNP concentrations.
    Humm K; Hezzell M; Sargent J; Connolly DJ; Boswood A
    J Small Anim Pract; 2013 Dec; 54(12):656-61. PubMed ID: 24283418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.